Skip to Main Content

Author Details

Tapio Visakorpi
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
1987
238
73
PMIDPaper TitleJournal TitlePublished Year
37140987Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases.Endocr Relat Cancer2023
37828555Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine.Genome Med2023
35228520miR-32 promotes MYC-driven prostate cancer.Oncogenesis2022
36219867Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen.Endocr Relat Cancer2022
36253447Retraction Note: CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus.Oncogene2022
35128089Spatial analysis of histology in 3D: quantification and visualization of organ and tumor level tissue environment.Heliyon2022
35151601Combining CAPRA-S With Tumor IDC/C Features Improves the Prognostication of Biochemical Recurrence in Prostate Cancer Patients.Clin Genitourin Cancer2022
34127815Chromatin-directed proteomics-identified network of endogenous androgen receptor in prostate cancer cells.Oncogene2021
33932111Expression and ERG regulation of PIM kinases in prostate cancer.Cancer Med2021
34489465Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse.Nat Commun2021
32343215Reply by Authors.J Urol2020
31660579Moderate-to-strong expression of FGFR3 and TP53 alterations in a subpopulation of choroid plexus tumors.Histol Histopathol2020
32068491Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate.J Urol2020
33033260Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy.Nat Commun2020
32611374Expression of the miR-200 family in tumor tissue, plasma and urine of epithelial ovarian cancer patients in comparison to benign counterparts.BMC Res Notes2020
32555329AR and ERG drive the expression of prostate cancer specific long noncoding RNAs.Oncogene2020
29137895A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer.Eur Urol Focus2019
31730483Phosphorylation of NFATC1 at PIM1 target sites is essential for its ability to promote prostate cancer cell migration and invasion.Cell Commun Signal2019
28984675Feasibility of Prostate PAXgene Fixation for Molecular Research and Diagnostic Surgical Pathology: Comparison of Matched Fresh Frozen, FFPE, and PFPE Tissues.Am J Surg Pathol2018
30234142Proteomics of prostate cancer - revealing how cancer cells master their messy genomes.Oncoscience2018
29988112Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases.Br J Cancer2018
30056367Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted Therapies.Transl Oncol2018
30467127PARP-1 regulates DNA repair factor availability.EMBO Mol Med2018
29728311Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.Pathol Res Pract2018
29662167Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.Nat Genet2018
29463415Endocrinology of prostate cancer.Mol Cell Endocrinol2018
29684099Comparative analysis of tissue reconstruction algorithms for 3D histology.Bioinformatics2018
29563510Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression.Nat Commun2018
29202480Differential impact of RB status on E2F1 reprogramming in human cancer.J Clin Invest2018
28827140In Vivo Expression of miR-32 Induces Proliferation in Prostate Epithelium.Am J Pathol2017
28379477Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas.Neuro Oncol2017
28468611Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas.BMC Cancer2017
28317907Analysis of spatial heterogeneity in normal epithelium and preneoplastic alterations in mouse prostate tumor models.Sci Rep2017
29269934The expression of AURKA is androgen regulated in castration-resistant prostate cancer.Sci Rep2017
28945760Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.PLoS Genet2017
28591577Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer.Cell Rep2017
27074291Amplification of the 9p13.3 chromosomal region in prostate cancer.Genes Chromosomes Cancer2016
28723516The Molecular Evolution of Castration-resistant Prostate Cancer.Eur Urol Focus2016
26436875Copy number increase of oncoprotein CIP2A is associated with poor patient survival in human head and neck squamous cell carcinoma.J Oral Pathol Med2016
26383637Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms.Prostate2016
27798103Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.Hum Mol Genet2016
27538859Incidence of Mucinous Metaplasia in the Prostate of FVB/N Mice (Mus musculus).Comp Med2016
27148588Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer.Cold Spring Harb Mol Case Stud2016
27502739Tumor features and survival after radical prostatectomy among antidiabetic drug users.Prostate Cancer Prostatic Dis2016
27113481Expressional profiling of prostate cancer risk SNPs at 11q13.5 identifies DGAT2 as a new target gene.Genes Chromosomes Cancer2016
27340920Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers.Oncotarget2016
27246339Measuring the Expression of microRNAs Regulated by Androgens.Methods Mol Biol2016
26689439Statin use and risk of disease recurrence and death after radical prostatectomy.Prostate2016
26806656The Potential of MicroRNAs as Prostate Cancer Biomarkers.Eur Urol2016
26939004Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.PLoS One2016
  • 1 - 50 of 238

Recommended Authors

Shuai Gao
Center for Personalized Cancer Therapy, University of Massachusetts Boston
Career Start Year 2012
Number of shared co-authors 10
Martina Kluth
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 2012
Number of shared co-authors 5
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 9
Changmeng Cai
Center for Personalized Cancer Therapy, University of Massachusetts Boston
Career Start Year 2006
Number of shared co-authors 11
Christina M??ller-Koop
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 2006
Number of shared co-authors 5
Tamara L Lotan
Johns Hopkins University School of Medicine
Career Start Year 2006
Number of shared co-authors 41
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 5
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 33
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 9
Adam Foye
University of California San Francisco
Career Start Year 2003
Number of shared co-authors 16
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 32
Luke A Selth
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 23
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 6
David S Rickman
Meyer Cancer Center
Career Start Year 2001
Number of shared co-authors 8
Yuzhuo Wang
University of British Columbia
Career Start Year 2000
Number of shared co-authors 32
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 25
Joshi J Alumkal
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 30
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 16
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 18
Claudia Hube-Magg
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1997
Number of shared co-authors 5
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 13
Volker Jung
Clinic of Urology and Pediatric Urology, University of Saarland
Career Start Year 1994
Number of shared co-authors 1
Rosina T Lis
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 25
Gyorgy Petrovics
Henry Jackson Foundation for the Advancement of Military Medicine (HJF)
Career Start Year 1990
Number of shared co-authors 46
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 30
Colin C Collins
University of British Columbia
Career Start Year 1988
Number of shared co-authors 39
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 5
Martin E Gleave
University of British Columbia
Career Start Year 1987
Number of shared co-authors 59
Massimo Loda
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 56
Philip W Kantoff
Memorial Sloan Kettering Cancer Center
Career Start Year 1981
Number of shared co-authors 56

Collaborators

Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 34
Olli Kallioniemi
Karolinska Institute
Co-authored papers 32
Leena Latonen
Foundation for the Finnish Cancer Institute
Co-authored papers 25
Robert L Vessella
University of Washington
Co-authored papers 22
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 18
Matti Annala
University of British Columbia
Co-authored papers 17
William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 15
Alfonso Urbanucci
Northwestern University Feinberg School of Medicine Chicago
Co-authored papers 14
Pekka Ruusuvuori
Institute of Biomedicine, University of Turku
Co-authored papers 11
Johanna Schleutker
Institute of Biomedicine, University of Turku
Co-authored papers 9
Guido Jenster
Erasmus University Medical Center
Co-authored papers 9
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 8
Wei Zhang
University of Manchester
Co-authored papers 7
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 6
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 6
Colin S Cooper
Norwich Medical School, University of East Anglia
Co-authored papers 6
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Co-authored papers 6
Henrik Gr??nberg
Karolinska Institute
Co-authored papers 6
Hayley C Whitaker
University College London
Co-authored papers 5
Freddie C Hamdy
University of Oxford
Co-authored papers 5
Christopher S Foster
The Institute of Cancer Research
Co-authored papers 5
Peter Van Loo
The Francis Crick Institute
Co-authored papers 5
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers 5
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 5
Ludmil B Alexandrov
Moores Cancer Center, university of california san diego
Co-authored papers 4
Adam Butler
Wellcome Sanger Institute
Co-authored papers 4
Johan Lindberg
Karolinska Institute
Co-authored papers 4
Mauno Vihinen
Lund University
Co-authored papers 4
Kimmo Kartasalo
Karolinska Institutet
Co-authored papers 4
Release 1.2